Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting.
Abstract
No abstract available
Author
Marzolini, Maria A V
Mehra, Varun
Thomson, Kirsty J
Tholouli, Eleni
Bloor, Adrian J C
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Snowden, John A
Byrne, Jennifer
Khan, Anjum
Gilleece, Maria H
Errico, Gerardo
Lozano, Sara
Hurst, Erin
Duncan, Nick
Pirrie, Jennifer
Crea, Philip
Carpenter, Ben
Pagliuca, Antonio
Peggs, Karl S
Mehra, Varun
Thomson, Kirsty J
Tholouli, Eleni
Bloor, Adrian J C
Parker, Anne
Lovell, Richard
Orchard, Kim
Publicover, Amy
Nicholson, Emma
Snowden, John A
Byrne, Jennifer
Khan, Anjum
Gilleece, Maria H
Errico, Gerardo
Lozano, Sara
Hurst, Erin
Duncan, Nick
Pirrie, Jennifer
Crea, Philip
Carpenter, Ben
Pagliuca, Antonio
Peggs, Karl S
Citations
Altmetric:
Date
2021-11-09
Type
Article
Subject
Haematology
Collections
Citation
Marzolini MAV, Mehra V, Thomson KJ, Tholouli E, Bloor AJC, Parker A, Lovell R, Orchard K, Publicover A, Nicholson E, Snowden JA, Byrne J, Khan A, Gilleece MH, Errico G, Lozano S, Hurst E, Duncan N, Pirrie J, Crea P, Carpenter B, Pagliuca A, Peggs KS. Letermovir prophylaxis in T-cell-depleted transplants: breakthrough and rebound infections in the postmarketing setting. Blood Adv. 2021 Nov 9;5(21):4500-4503. doi: 10.1182/bloodadvances.2021005637
Journal / Source Title
Blood Advances
DOI
10.1182/bloodadvances.2021005637
PMID
34614515
Publisher
American Society of Hematology
Publisher’s URL
https://ashpublications.org/bloodadvances